HHS Accused Of Overstepping Role In Drug Discount Program
By Adam Lidgett · October 7, 2021, 4:57 PM EDT
The U.S. Department of Health and Human Services is wrongly barring drugmakers from requiring claims information from certain health providers when they request a ceiling price for drugs under a federal...
To view the full article, register now.